Physician

Naim Joseph Salloum, M.D.

According to 2025 Medicare claims, Naim Salloum, M.D. (NPI: 1205870656) practices radiation oncology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is CANCER CARE OF HATTIESBURG PLLC (NPI: 1215542725; TIN: 85-2721552) and primary practice location at 39401-7233.

Salloum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 7,038 HCPCS/CPT codes, and received $483,190 in Medicare payments. The top billing code was 77338 (Design and construction of radiation treatment device for high precision radiation therapy). Part D data shows 418 prescription claims across 162 beneficiaries totaling $720,575 in drug costs, led by Erleada (Apalutamide). DME data shows 43 claims. Open Payments data shows 18 records totaling $493. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $22,716 to $720,575. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $2,269 and ending at $98.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,007	9,733	$617,786
2016	1,034	9,996	$602,460
2017	1,133	10,036	$599,278
2018	898	12,970	$821,776
2019	716	10,527	$662,437
2020	476	8,808	$597,495
2021	402	8,281	$568,031
2022	406	8,060	$563,838
2023	347	8,054	$538,479
2024	337	7,038	$483,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	179	645	$22,716
2016	177	595	$126,254
2017	189	646	$112,276
2018	240	664	$37,688
2019	180	451	$10,336
2020	154	378	$48,226
2021	152	427	$158,117
2022	164	431	$248,386
2023	145	405	$579,675
2024	162	418	$720,575

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	18	$4,749
2016	24	24	$3,647
2017	N/R	110	$8,151
2018	27	150	$16,643
2019	N/R	86	$12,336
2020	N/R	120	$12,682
2021	N/R	103	$9,245
2022	N/R	58	$6,580
2023	N/R	51	$6,788
2024	N/R	43	$6,316

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77338	Design and construction of radiation treatment device for high precision radiation therapy	155	294	$166
77427	Radiation treatment management, 5 treatment sessions	152	683	$137
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	166	166	$129
77263	Complex radiation therapy planning	208	228	$122
77300	Calculation of radiation therapy dose	182	979	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	40	1,200	$580,373
Abiraterone Acetate	Abiraterone Acetate	12	360	$30,577
Sucralfate	Sucralfate	21	515	$1,568
Hydrocortisone	Hydrocortisone	34	585	$489
Dexamethasone	Dexamethasone	20	456	$405

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	24	$4,609
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	19	$1,707

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$493	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Naim Joseph Salloum, M.D.?

Tedicare shows public-source Medicare data for Naim Joseph Salloum, M.D. (NPI 1205870656), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Naim Joseph Salloum, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Naim Joseph Salloum, M.D.?

Naim Joseph Salloum, M.D. is linked to CANCER CARE OF HATTIESBURG PLLC (billing NPI 1215542725) in the available physician profile data.

Does Naim Joseph Salloum, M.D. have Open Payments data?

Naim Joseph Salloum, M.D. has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.